Smoking Cessation In Patients With Squamous Cell Cancer Of The Head And Neck Undergoing Radiation Therapy With Or Without Chemotherapy

What we are studying

It is estimated that 84% of head and neck cancer patients smoking at the time of their diagnosis will quit smoking without any specialized help, but unfortunately about 60% of patients will re-start smoking after treatment finishes. It is so important for your health to be able to not smoke again and we want to see if there are treatments that are better than others to help you not re-start smoking. Many patients feel anxious and depressed while taking treatment for their head and neck cancer and later while recovering from treatment, and we want to compare a medication that can also help with depression signs called bupropion (Zyban®) with other treatments known to help patients to stop smoking and to stay away from re-starting smoking. All medications used in this study are approved by FDA as strategies to help with quitting smoking.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Patients receive definitive treatment at WFU Cancer Center or at MUSC Cancer Center
  • Active smoker

What is involved

  • Self-Report smoking assessment (journal)
  • Smoking cessation form

Compensation

Parking validation for study related office visits

Contact Information

Study Coordinator
Sharon Averill
Email
saverill@wakehealth.edu
Phone
336-713-6925

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.